Bolt Biotherapeutics, Inc.BOLT
Price (close)
$3.58
Market cap
$6.9M
P/E
—
Revenue (TTM)
$4.7M
Net income
-$28.7M
Dividend yield
—
1-year total return
-35.3%
Net margin
-611.5%
Revenue growth
12.8%
Debt / equity
—
What Bolt Biotherapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $231,000 | $1.3M | $5.7M | $7.9M | $7.7M | $7.7M |
| Net income | -$60.7M | -$98.6M | -$88.1M | -$69.2M | -$63.1M | -$33.4M |
| Free cash flow | -$50.6M | -$59.4M | -$78.5M | -$69.7M | -$61.3M | -$39.9M |
More on BOLT.
- Bolt Biotherapeutics, Inc. summary
- Bolt Biotherapeutics, Inc. financial statements
- Bolt Biotherapeutics, Inc. key metrics
- Bolt Biotherapeutics, Inc. health scores and style box
- Bolt Biotherapeutics, Inc. earnings
- Bolt Biotherapeutics, Inc. dividends
- Bolt Biotherapeutics, Inc. valuation
- Bolt Biotherapeutics, Inc. ownership and insiders
- Bolt Biotherapeutics, Inc. peers
Figures from Bolt Biotherapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.